Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pleural Effusion, Malignant 4 Breast Neoplasms 4 Immunoglobulin Light-chain Amyloidosis 3 Colorectal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Pancreatic Neoplasms 2 Neoplasm Metastasis 2 Mycosis Fungoides 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, Non-Hodgkin 2 Exanthema 2 Amyloidosis 2 Waldenstrom Macroglobulinemia 1 Urologic Neoplasms 1 Tuberous Sclerosis 1 Triple Negative Breast Neoplasms 1 Tissue Adhesions 1 Skin Toxicity 1 Sezary Syndrome 1 Ras-wildtype Colorectal Cancer 1 Polyps 1 Polycystic Ovary Syndrome 1 Pleural Neoplasms 1 Pain 1 Ovarian Neoplasms 1 Neurofibromatosis 2 1 Neoplasms, Second Primary 1 Neoplasms 1 Myoma 1 Menstruation Disturbances 1

Interventions

Fentanyl 27 Analgesia 23 Morphine 20 Acupuncture Therapy 18 Surveys and Questionnaires 16 Oxycodone 16 Zoledronic Acid 15 Acetaminophen 14 Therapeutics 13 Radiotherapy 13 Psychiatric Rehabilitation 13 Ketamine 13 Methadone 11 Lidocaine 11 Hydromorphone 11 Bupivacaine 11 nabiximols 10 Ibandronic Acid 10 Ropivacaine 9 Early Intervention, Educational 7 Analgesics, Opioid 7 Saline Solution 6 Music Therapy 6 Cryotherapy 6 Cryosurgery 6 Yoga 5 Water 5 Tapentadol 5 Pregabalin 5 Methods 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Pain × Doxycycline × Clear all

NCT01847976 2019-09-06

OTT12-05

Ottawa Hospital Research Institute

Phase 2 Completed

Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡